Coherus Oncology Inc (CHRS)

Coherus Oncology Inc Azioni (CHRS) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	16.22%14.31	12.31	12.75	11.57	10.25
Cost Of Revenue	11.22%4.24	3.81	4.05	3.72	3.40
	9.31%20.95	23.10	-	-	-
Selling, General, and Administrative	9.31%20.95	23.10	-	-	-
Research and Development	0.47%21.44	21.54	-	-	-
Interest Income/Expense	6.27%2.32	2.19	2.25	2.33	2.28
Costs And Expenses	3.76%46.64	48.46	58.63	55.90	55.74
Depreciation and Amortization	2.16%0.86	0.88	0.90	0.97	1.02
Operating Income/Loss	10.57%-32.33	-36.15	-45.88	-44.33	-45.49
Income/Loss From Continuing Operations Before Tax	9.71%-33.35	-36.94	-46.35	-44.52	-44.86
Income/Loss From Continuing Operations After Tax	9.71%-33.35	-36.94	-46.35	-44.52	-44.86
Income/Loss From Discontinued Operations, Net Of Tax	1,014%12.72	-1.39	8.70	8.99	342.63
	46.17%-20.63	-38.33	-37.64	-35.53	297.77
Attributable To Parent	46.17%-20.63	-38.33	-37.64	-35.53	297.77
Basic Average Shares	13.50%154.82	136.40	1.09	116.23	116.08
Diluted Average Shares	13.50%154.82	136.40	1.09	116.23	116.08
Basic Earnings Per Share	53.57%-0.13	-0.28	-0.34	-0.31	2.57
Diluted Earnings Per Share	53.57%-0.13	-0.28	-0.34	-0.31	2.57